Lessons to be learned from the ebolavirus outbreak in west africa

Emerging Microbes and Infections

Volumn 3, Issue , 2014, Pages

  Klenk, Hans Dieter ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; EBOLA VACCINE; MONOCLONAL ANTIBODY; SMALL INTERFERING RNA;

AFRICA; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; HEALTH CARE PERSONNEL; HUMAN; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; DEATH; DEMOCRATIC REPUBLIC CONGO; EBOLA VIRUS; EXPERIMENTAL THERAPY; GUINEA; LIBERIA; NONHUMAN; SIERRA LEONE; VIRUS VIRULENCE; WORLD HEALTH ORGANIZATION;

EBOLA VIRUS;

EID: 84907378164     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/emi.2014.68     Document Type: Note

References (2)

1. Jones SM, Feldmann H, Ströher U et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 2005; 11: 786-790.
2. Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ. Development of a preventive vaccine for Ebola virus infection in primates. Nature 2000; 408: 605-609.